MIRABEGRON ER 25 MG TABLET

mirabegron
$9.4344per EA

Strength

25 mg/1

NDC

68180015106

Classification

Generic

Dosage Form

TABLET, FILM COATED, EXTENDED RELEASE

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

MIRABEGRON

Approval Type

Generic (ANDA)

FDA Application

ANDA209485

On Market Since

4/19/2024

Pharmacological Classes

Adrenergic beta3-Agonists
Cytochrome P450 2D6 Inhibitors
Cytochrome P450 3A Inhibitors
P-Glycoprotein Inhibitors
beta3-Adrenergic Agonist

Price History

1W

0.0%

1M

-1.3%

3M

-2.5%

6M

-6.8%

1Y

-5.6%

3Y

N/A

5Y

N/A

All

+16.5%